SCHEMBL10508142

SCHEMBL10508142

COc1ccc(CCCn2ccnc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.69
KMT2A Q03164 3/20 0.69
ATM Q13315 1/20 0.69
CYP3A4 P08684 3/20 0.66
TP53 P04637 2/20 0.66
CYP1A2 P05177 2/20 0.66
CYP2C9 P11712 2/20 0.66
TSHR P16473 2/20 0.66
CYP2D6 P10635 1/20 0.66
NFKB1 P19838 1/20 0.66
CYP2C19 P33261 1/20 0.66
MTOR P42345 1/20 0.66
RAB9A P51151 1/20 0.66
HIF1A Q16665 1/20 0.66
CYP19A1 P11511 1/20 0.66
MAPT P10636 3/20 0.65
TDP1 Q9NUW8 3/20 0.65
GMNN O75496 1/20 0.65
LMNA P02545 1/20 0.65
BLM P54132 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5045082 0.95 MEN1 (0.68) MEN1KMT2AATMCYP3A4TP53
Bromide SCHEMBL10837938 0.94 MEN1 (0.66) MEN1KMT2AATMCYP3A4TP53
SCHEMBL9263335 0.94 MEN1 (0.66) MEN1KMT2AATMCYP3A4TP53
SCHEMBL8535355 0.94 MEN1 (0.66) MEN1KMT2AATMCYP3A4TP53
SCHEMBL19390253 0.83 CYP19A1 (0.71) CYP19A1ALDH1A1HMOX1TBXAS1
SCHEMBL10645328 0.82 MAPT (0.56) MEN1KMT2AATMCYP3A4TP53
SCHEMBL8543266 0.82 CYP3A4 (0.52) MEN1KMT2AATMCYP3A4TP53
SCHEMBL12045347 0.82 HMOX1 (0.84) KMT2ACYP19A1HMOX1TBXAS1
SCHEMBL14416015 0.82 MEN1 (0.61) MEN1KMT2AATMCYP3A4TP53
SCHEMBL4539675 0.81 TP53 (0.69) MEN1KMT2ACYP3A4TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4863944-A Dopamine-β-hydroxylase inhibitors SMITHKLINE BECKMAN CORPORATION (US) 1989-09-05 US disclosed
EP-0125783-B1 DOPAMINE-BETA-HYDROXYLASE INHIBITORS SMITHKLINE BECKMAN CORPORATION (US) 1989-01-04 EP disclosed
US-4772723-A Dopamine β-hydroxylase inhibitors SMITHKLINE BECKMAN CORPORATION (US) 1988-09-20 US disclosed
US-4532331-A 1-Benzyl-2-aminomethyl imidazole derivatives SMITHKLINE BECKMAN CORPORATION (US) 1985-07-30 US disclosed
EP-0125783-A1 Dopamine-beta-hydroxylase inhibitors SMITHKLINE BECKMAN CORPORATION (US) 1984-11-21 EP disclosed